Clinical Trial Update: Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TAC (Docetaxel, Doxorubicin, Cyclophosphamide) versus 5FAC (5-Fluorouracil, Doxorubicin, Cyclophosphamide) as adjuvant therapy for breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil, Doxorubicin, Cyclophosphamide (5FAC)
• 5FAC
• Docetaxel, Doxorubicin (A), Cyclophosphamide (TAC)
• TAC

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2020-12-04